Dubai, UAE (Enmaeya News) – Miracell, a South Korean biotechnology company specializing in stem cell therapies, is expanding its operations into Dubai to capitalize on the growing demand for regenerative medicine in the Middle East.
The company aims to establish a stem cell treatment center in Dubai, collaborating with local medical institutions to offer advanced regenerative therapies. This strategic move aligns with Dubai's vision to become a global hub for medical innovation and stem cell research by 2030.
Dubai has been investing heavily in stem cell technology, with the Dubai Health Authority implementing a robust regulatory framework to ensure the safe and ethical use of stem cell research and therapy.
The city boasts world-class research centers and institutions, such as the Mohammed Bin Rashid University of Medicine and Health Sciences, which focus on both basic science and translational research to develop innovative therapies. Additionally, Dubai Healthcare City has opened the first and only Good Manufacturing Practice (GMP) cleanroom graded facility in the UAE, capable of manufacturing and storing stem cells.
The company's expansion into the Middle East underscores its commitment to advancing regenerative medicine and contributing to the region's healthcare advancements.
